Trifluoperazine
تریفلوپرازین
🧠 Nervous SystemPhenothiazine antipsychotic
Market / country: 🇺🇸 USA
Stelazine (US)
🧮 Dose calculator
Anxiety and tension · Regimen source: FDA Trifluoperazine · Dosage and Administration-Adults
- • Max 6 mg/day and no longer than 12 weeks. FDA Trifluoperazine · Dosage and Administration-Adults
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to phenothiazines; coma or marked CNS depression; blood dyscrasias, marrow depression, liver damage. FDA Trifluoperazine · Contraindications
- ⚠️ Boxed warning: increased mortality in elderly patients with dementia-related psychosis. FDA Trifluoperazine · Boxed Warning
Formulations
- 1 mg tablet — tablet 🇺🇸 USA FDA Trifluoperazine · How Supplied
- 2 mg tablet — tablet 🇺🇸 USA FDA Trifluoperazine · How Supplied
- 5 mg tablet — tablet 🇺🇸 USA FDA Trifluoperazine · How Supplied
- 10 mg tablet — tablet 🇺🇸 USA FDA Trifluoperazine · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Trifluoperazine · Pregnancy
“Trifluoperazine hydrochloride should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.”
- 🤱 BreastfeedingDangerous / avoid
Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Trifluoperazine · Nursing Mothers
“Because of the potential for serious adverse reactions in nursing infants from trifluoperazine, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.”
- 👶 ChildrenNo data
The source for this drug has no section for this group.
- 👴 Older adultsDangerous / avoid
Label: serious warning or avoid in older adults. FDA Trifluoperazine · Boxed Warning
“Increased Mortality in Elderly Patients with Dementia-Related Psychosis Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA040209
- DailyMed (FDA label)FDA Trifluoperazine
- MedlinePlus (NIH)Trifluoperazine
- WHO ATC/DDDN05AB06
- Darooyab (Iran)Trifluoperazine
🇮🇷 Registered in Iran Darooyab · G-1362/Trifluoperazine
Dosage forms with Iranian generic codes, per Darooyab.
- 02191 · TRIFLUOPERAZINE 10MG TAB · قرص تریفلوئوپرازین ۱۰ میلیگرم
- 01253 · TRIFLUOPERAZINE 1MG TAB · قرص تریفلوئوپرازین ۱ میلیگرم
- 01254 · TRIFLUOPERAZINE 1MG/1ML AMP · آمپول تریفلوئوپرازین ۱ میلیگرم / ۱ میلیلیتر
- 01255 · TRIFLUOPERAZINE 2MG TAB · قرص تریفلوئوپرازین ۲ میلیگرم
- 01256 · TRIFLUOPERAZINE 5MG TAB · قرص تریفلوئوپرازین ۵ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Trifluoperazine · How SuppliedFDA Trifluoperazine · Dosage and Administration-AdultsFDA Trifluoperazine · Dosage and Administration-Schizophrenia in ChildrenFDA Trifluoperazine · ContraindicationsFDA Trifluoperazine · Boxed WarningFDA Trifluoperazine · PregnancyFDA Trifluoperazine · Nursing MothersFDA Trifluoperazine · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1362/Trifluoperazine
- Clinical review⚠ Unverified